TL;DR
Get wellness gear delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
Shiftwave is demonstrating its Arc wellness chair and Active Regulation software platform at Eudemonia in West Palm Beach, Florida, Nov. 6-8. The $20,000 chair combines pulsed pressure waves, guided breathwork and audio experiences; first deliveries are expected in mid-February. Company-reported field studies found improvements in participants’ self-reported measures, but lacked control groups and cannot establish that the technology caused those changes.
Shiftwave is presenting its Arc wellness chair and accompanying Active Regulation software at Eudemonia in West Palm Beach, Florida, from Nov. 6-8, expanding the company’s product line for guided stress management, recovery and performance preparation. The chair is priced at $20,000, and the company expects first deliveries in mid-February.
The Arc combines pulsed pressure waves, guided breathwork and audio experiences in a reclining chair designed by Copenhagen-based industrial designer Jakob Wagner. Shiftwave says the sessions are intended to help users manage stress, support recovery and prepare for physical or mental performance. Those are the company’s stated aims, not established clinical outcomes.
The accompanying Active Regulation platform pairs Shiftwave hardware with software that recommends sessions based on how users say they feel, their goals and the time they have available. Its library contains more than 100 protocols, developed with trainers, psychologists, sports performance coaches and researchers. Some sessions use the company’s patented BioDrive technology, which reads a user’s pulse through a chair sensor and adjusts vibration patterns in real time.
Users can record sessions using four platform metrics—Engagement, Resilience, Renewal and Inner Form—and connect wearable devices. The software is available through an iPhone and iPad app; Shiftwave says Android support is planned. The company’s existing Pro chair is also compatible with the platform.
A High-Cost Wellness Platform
The Arc brings together hardware, personalized software and session tracking in a product aimed at people seeking structured tools for stress management and performance routines. Its $20,000 price places it at a premium level, making the strength of its evidence and the practical value of its software relevant questions for prospective buyers and organizations considering a purchase.
Shiftwave’s approach also reflects a wider wellness-market interest in tools that combine physiological sensing with guided experiences. The company says BioDrive can adapt sessions using pulse readings, but the product description alone does not show whether those adjustments produce better outcomes than a fixed session, ordinary rest or other approaches. The distinction matters because users may interpret personalized feedback and named metrics as evidence of health benefits, even when the measures are not clinical diagnoses.
For teams and institutions evaluating the technology, the company’s reported use across professional sports and performance settings may indicate commercial interest. It does not, by itself, establish effectiveness. The ongoing controlled studies could provide more informative evidence than the uncontrolled field reports Shiftwave has described so far.
Products Worth Considering
Philips Sonicare ProtectiveClean 5300 Rechargeable Electric Toothbrush with 3 Brush Heads, Black
Withings BPM Connect Wi-Fi and Bluetooth Blood Pressure Monitor
BowFlex Results Series SelectTech Adjustable Dumbbells (Pair)
As an affiliate, we earn on qualifying purchases.
What Shiftwave’s Research Reports
Shiftwave says its technology is designed to influence the autonomic nervous system, which regulates involuntary processes such as heart rate and aspects of the body’s stress response. The company describes its chairs as using vibration and guided breathing to alternate between stimulation and calming experiences. These descriptions outline the intended mechanism; they do not independently verify the claimed effects.
In an October 2026 research overview, Shiftwave reported that 11 completed field studies involving 362 people found improvements in self-reported stress, anxiety, pain and relaxation after sessions. One pilot included 22 NCAA Division I athletes at UC Santa Barbara, who reported better mental readiness and lower stress following sessions over two weeks. The company says its research has also involved firefighters, police officers and military personnel.
The reported studies did not include control groups. That limits what can be concluded: the findings cannot determine whether changes resulted from Shiftwave sessions rather than rest, expectations or other factors. Shiftwave says eight controlled trials are in progress or awaiting approval, including studies involving military personnel and researchers at Ohio State University, Appalachian State University and other institutions.
“We saw in the lab that gentle wasn’t enough to get people unstuck, so we kept adding power until we could reliably create a shift.”
— Shiftwave co-founder and CEO Mike North, Ph.D.
Evidence Still Needs Controls
The company’s overview reports self-reported changes after sessions, but the completed field studies had no control groups. The source material does not provide enough detail to assess each study’s design, measurement methods or results individually, and the reported improvements do not establish that the chair caused them.
It is also unclear how the four platform metrics are calculated, whether they have been independently validated, or what evidence supports the software’s personalized recommendations. Shiftwave says controlled trials are in progress or awaiting approval, but has not provided results for those trials in the material cited here. The timing of their completion and publication is not specified.
Deliveries and Trials Ahead
Shiftwave is demonstrating the Arc and Active Regulation platform at Eudemonia from Nov. 6-8. The company expects the first Arc deliveries in mid-February. The source material does not specify how many units will be available, where deliveries will begin or whether the expected schedule has changed since the announcement.
Further evidence may come from the eight controlled trials the company says are underway or awaiting approval. Their methods, findings and publication dates will help clarify how the reported session effects compare with control conditions. Until results are available, the field-study findings should be understood as preliminary company-reported observations rather than proof of efficacy.
Key Questions
What is Shiftwave unveiling at Eudemonia?
Shiftwave is demonstrating the Arc wellness chair and its Active Regulation software platform at the West Palm Beach event, scheduled for Nov. 6-8.
How much does the Shiftwave Arc cost?
The Arc is listed at $20,000. The source material does not provide additional information about financing, accessories or service costs.
What does the Arc combine?
The reclining chair combines pulsed pressure waves, guided breathwork and audio experiences. Some sessions use BioDrive, which Shiftwave says measures pulse through a chair sensor and adjusts vibration patterns in real time.
Do the reported studies prove that Shiftwave reduces stress?
No. Shiftwave reports improvements in self-reported measures across 11 field studies, but those studies had no control groups. The findings cannot establish that the sessions caused the changes or performed better than rest or participants’ expectations.
When are deliveries expected, and is the software available on Android?
First Arc deliveries are expected in mid-February. The software is available on iPhone and iPad, while Shiftwave says Android support is planned; no Android release date is provided.
Source: athletechnews.com
